| ZBRA |
Report |
Revenue |
BEAT |
pred ~$1.515B vs. cons $1.499B |
MEDIUM |
| ZBRA |
Report |
Organic revenue growth |
BEAT |
pred ~5.9% vs. cons 5.64% |
MEDIUM |
| ZBRA |
Report |
Non-GAAP EPS |
BEAT |
pred ~$4.48 vs. cons $4.37 |
MEDIUM |
| ZBRA |
Guide |
Q3 2026 revenue |
LOWER |
guide ~$1.485B vs. cons $1.503B |
LOW |
| ZBRA |
Guide |
FY 2026 non-GAAP EPS |
UNCHANGED |
guide ~$18.50 midpoint vs. cons $18.58 |
MEDIUM |
| ZBRA |
Guide |
FY 2026 adjusted EBITDA margin |
UNCHANGED |
guide ~22.0% vs. cons ~22.2% |
MEDIUM |
| ZBRA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
LOW |
| ZBRA |
Return |
5-day cumulative residual |
-4.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Q3 estimate pressure outweighs a modest Q2 beat |
LOW |